A practical method for determining the rate of covalent modification of fragments and leads.
Ontology highlight
ABSTRACT: The clinical success of covalent drugs such as sotorasib has renewed interest in covalency for rational drug design. The most rigorous potency metric for covalent modifiers is the second-order rate constant kinact/KI. However, existing methods for measuring kinact/KI are resource-intensive and involve complex data interpretation. We describe the diagonal dose-response time-course (dDRTC), an efficient mass spectrometry-based method for determining kinact/KI, enabling routine kinact/KI quantification earlier in programs and accelerating SAR interpretation for lead discovery. We apply dDRTC to a dozen covalent fragment and lead-like modifiers for three targets, KRASG12C and two E3 ligase comple
SUBMITTER: Jeon J
PROVIDER: S-EPMC12714714 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA